Global Health Insights

A new $540 million, 10-year investment from the Gates Foundation will support IHME’s global public goods: the Global Burden of Disease Study (GBD), forecasting of future health scenarios, and tracking of financing for global health. We discuss the investment with IHME Director Dr. Christopher Murray, including how GBD will expand to nearly 5,000 locations and why timely, local health evidence matters as global health funding declines.

Childhood cancer is the eighth-leading cause of childhood death globally and causes more deaths than measles, tuberculosis and HIV/AIDS, with outcomes largely determined by resource availability, according to the latest findings from the Global Burden of Disease (GBD) 2023 study published in The Lancet.

New breast cancer cases in women are predicted to increase globally from 2.3 million in 2023 to more than 3.5 million in 2050.

The research examined the distribution of delivery location by health facility in 130 LMICs from 1995 to 2023 to improve access, quality, and equity.

Sexual violence against children (SVAC) and intimate partner violence (IPV) against women are two of the most devastating yet persistently underrecognized global health challenges and rank among the top risks for mortality and morbidity worldwide, according to research published in The Lancet.

The number of adults living with chronic kidney disease (CKD) has more than doubled since 1990, reaching nearly 800 million, and signaling a growing global health crisis. CKD was the ninth-leading cause of death worldwide (totaling 1.5 million people) in 2023, according to research using IHME's Global Burden of Disease 2023 study data published in The Lancet.

In 2021, there were an estimated 92,800 deaths attributable to bacterial AMR in the WHO Eastern Mediterranean Region (EMR), according to a recent study published in The Lancet Public Health using GBD study data.

In 2021, there were an estimated 166 million sepsis cases and 21.4 million all-cause sepsis-related deaths globally, representing 31.5% of total global deaths.

Headache disorders, especially migraine and tension-type headache, are among the most common and disabling conditions worldwide

Despite population growth and aging, the 2023 global age-standardized mortality rate declined 67% since 1950

Cancer was estimated to be the second-leading cause of death globally in 2023 with cancer deaths expected to rise to over 18 million in 2050, according to new research published in The Lancet.

A major global study finds cardiovascular disease burden is rising worldwide, driven by population growth and aging outpacing risk reduction efforts. Burden is highest in parts of Asia, sub-Saharan Africa, and Eastern Europe — not wealthy nations — because healthcare access makes a real difference. High blood pressure is the leading driver today, but rapidly rising obesity and diabetes are the biggest future threat.

Low bone mineral density (BMD) is not one of the well-known risk factors to health, but it has a particular effect on bones—weaker and more vulnerable to fracture.

Lauryn Stafford, first author and researcher at IHME, presents findings from a new study that analyzed the diabetes care cascade

New research from IHME evaluates health care systems across 3,110 US counties to understand which are performing the best and which are not.